MigVax is a startup developing Migvax-101, a novel oral subunit COVID-19 vaccine that has demonstrated effectivity in pre-clinical tests as a booster for previously vaccinated persons
| Website | https://www.migvax.com/home |
| Employees | 5 (1 on RocketReach) |
| Founded | 2020 |
| Phone | +972 4-695-3511 |
| Industry | Pharmaceutical Manufacturing, Drug Discovery, Pharmaceuticals |
| Keywords | Vaccine Development, Pharmaceutical, Biotechnology, Clinical Trials, Drug Development, Preclinical Studies, Immunology, Infectious Disease, Therapeutics, Health Technology, Public Health, Life Sciences, Biopharma |
| Competitors | Moderna Therapeutics, Pfizer, Novavax, Johnson & Johnson, GSK, Sanofi, AstraZeneca, Merck & Co., Inc., Vaxart, Inc., INOVIO Pharmaceuticals, Inc. +35 more (view full list) |
Looking for a particular MigVax employee's phone or email?
MigVax Questions
1 people are employed at MigVax.
Related Companies
G2Crowd Trusted
300K+
Plugin Users
